Drug Discovery Chemistry 2013

Drug Discovery Chemistry is the leading discovery event in medicinal chemistry. Focused on novel small molecules as therapeutic targets, with a strong emphasis on a chemistry-based approach, this unique event brings together top experts with backgrounds in medicinal chemistry, biochemistry and life sciences to discuss cutting-edge research in the important areas of:

Anti-Inflammatories

Kinase Inhibitor Chemistry

Fragment-Based Drug Discovery

Protein-Protein Interactions

Constrained Peptides & Macrocyclics Drug Discovery

GPCR-Based Drug Design

Speakers

Samarjit Patnaik, Ph.D., Research Scientist, National Center for Advancing Translational Sciences, NIH

Peter H. Schafer, Ph.D., Senior Principal Investigator, Translational Development, Celgene Corporation

C. Eric Schwartz, Ph.D., Senior Director, Chemistry, Celgene Avilomics Research

Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.

Suvit Thaisrivongs, Ph.D., Executive Director, Chemistry, Pfizer

and many more.